Similarly, He et al. generated reconstructed-BCMA nanovesicles (NVs) from the membrane of HEK-293T cells and verified their potential to target MM cells along with the synergistic anti-MM effects with a lower dose of BTZ mechanically via the remained capacity of BCMA to conjugate with APRIL/BAFF [126]. Here, CASC3 is linked to Miyoshi myopathy.